143 related articles for article (PubMed ID: 17881394)
1. Oxidative stress and excitotoxicity: a therapeutic issue in multiple sclerosis?
Gonsette RE
Mult Scler; 2008 Jan; 14(1):22-34. PubMed ID: 17881394
[TBL] [Abstract][Full Text] [Related]
2. The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis.
Rossi S; Bernardi G; Centonze D
Exp Neurol; 2010 Jul; 224(1):92-102. PubMed ID: 20353778
[TBL] [Abstract][Full Text] [Related]
3. Postsynaptic mechanisms of excitotoxicity: Involvement of postsynaptic density proteins, radicals, and oxidant molecules.
Forder JP; Tymianski M
Neuroscience; 2009 Jan; 158(1):293-300. PubMed ID: 19041375
[TBL] [Abstract][Full Text] [Related]
4. Antioxidants and polyunsaturated fatty acids in multiple sclerosis.
van Meeteren ME; Teunissen CE; Dijkstra CD; van Tol EA
Eur J Clin Nutr; 2005 Dec; 59(12):1347-61. PubMed ID: 16118655
[TBL] [Abstract][Full Text] [Related]
5. Excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain: antioxidant and neuroprotective effects of L-carnitine.
Silva-Adaya D; Pérez-De La Cruz V; Herrera-Mundo MN; Mendoza-Macedo K; Villeda-Hernández J; Binienda Z; Ali SF; Santamaría A
J Neurochem; 2008 May; 105(3):677-89. PubMed ID: 18194214
[TBL] [Abstract][Full Text] [Related]
6. Excitotoxins, Mitochondrial and Redox Disturbances in Multiple Sclerosis.
Rajda C; Pukoli D; Bende Z; Majláth Z; Vécsei L
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208701
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of glutaredoxin but not glutathione loss leads to mitochondrial dysfunction in female mice CNS: implications in excitotoxicity.
Diwakar L; Kenchappa RS; Annepu J; Ravindranath V
Neurochem Int; 2007 Jul; 51(1):37-46. PubMed ID: 17512091
[TBL] [Abstract][Full Text] [Related]
8. Association of alpha-synuclein immunoreactivity with inflammatory activity in multiple sclerosis lesions.
Lu JQ; Fan Y; Mitha AP; Bell R; Metz L; Moore GR; Yong VW
J Neuropathol Exp Neurol; 2009 Feb; 68(2):179-89. PubMed ID: 19151622
[TBL] [Abstract][Full Text] [Related]
9. [The role for oxidative stress in neurodegenerative diseases].
Shibata N; Kobayashi M
Brain Nerve; 2008 Feb; 60(2):157-70. PubMed ID: 18306664
[TBL] [Abstract][Full Text] [Related]
10. Thrombin-induced oxidative stress contributes to the death of hippocampal neurons: role of neuronal NADPH oxidase.
Park KW; Jin BK
J Neurosci Res; 2008 Apr; 86(5):1053-63. PubMed ID: 18183616
[TBL] [Abstract][Full Text] [Related]
11. Neurodegeneration in multiple sclerosis: the role of oxidative stress and excitotoxicity.
Gonsette RE
J Neurol Sci; 2008 Nov; 274(1-2):48-53. PubMed ID: 18684473
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress and the pathogenesis of neurodegenerative disorders.
Reynolds A; Laurie C; Mosley RL; Gendelman HE
Int Rev Neurobiol; 2007; 82():297-325. PubMed ID: 17678968
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress and neurotoxicity.
Sayre LM; Perry G; Smith MA
Chem Res Toxicol; 2008 Jan; 21(1):172-88. PubMed ID: 18052107
[TBL] [Abstract][Full Text] [Related]
14. Ceftriaxone rescues hippocampal neurons from excitotoxicity and enhances memory retrieval in chronic hypobaric hypoxia.
Hota SK; Barhwal K; Ray K; Singh SB; Ilavazhagan G
Neurobiol Learn Mem; 2008 May; 89(4):522-32. PubMed ID: 18304843
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial dysfunction plays a key role in progressive axonal loss in Multiple Sclerosis.
Andrews HE; Nichols PP; Bates D; Turnbull DM
Med Hypotheses; 2005; 64(4):669-77. PubMed ID: 15694681
[TBL] [Abstract][Full Text] [Related]
16. Enhanced number and activity of mitochondria in multiple sclerosis lesions.
Witte ME; Bø L; Rodenburg RJ; Belien JA; Musters R; Hazes T; Wintjes LT; Smeitink JA; Geurts JJ; De Vries HE; van der Valk P; van Horssen J
J Pathol; 2009 Oct; 219(2):193-204. PubMed ID: 19591199
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant therapy in multiple sclerosis.
Mirshafiey A; Mohsenzadegan M
Immunopharmacol Immunotoxicol; 2009; 31(1):13-29. PubMed ID: 18763202
[TBL] [Abstract][Full Text] [Related]
18. Biological indicators of the neurodegenerative phase of multiple sclerosis.
Zaffaroni M
Neurol Sci; 2003 Dec; 24 Suppl 5():S279-82. PubMed ID: 14652789
[TBL] [Abstract][Full Text] [Related]
19. Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage.
Vercellino M; Merola A; Piacentino C; Votta B; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
J Neuropathol Exp Neurol; 2007 Aug; 66(8):732-9. PubMed ID: 17882017
[TBL] [Abstract][Full Text] [Related]
20. Calcium ions in neuronal degeneration.
Wojda U; Salinska E; Kuznicki J
IUBMB Life; 2008 Sep; 60(9):575-90. PubMed ID: 18478527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
